Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Ginkgo Bioworks Holdings, Inc.

DNA · NYSE · CIK 0001830214 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

11 Form 4 transaction lines observed in the same window
5 sales · 6 option, withholding, award, gift or other lines

Last qualifying purchase2024-05-15 · Sankar Shyam · $512.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Coen Steven P.See remarks
○▼○▼○▼▼
HENRY CHRISTIAN ODirector
▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-05-15 · Sankar Shyam.

Recent Form 4 activity

0Purchases
18Sales
25Other Form 4 lines
15SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING5 sale line(s) · context only
OTHER6 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
7,315,221
Previous report
7,166,128
Avg daily volume
2,735,902
Days to cover
2.7

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-05-15Sankar ShyamPurchase (P)Class A Common Stock625,000USD 0.82USD 512,500SEC filing ↗
2024-05-14SLOAN HARRYPurchase (P)Class A Common Stock297,619USD 0.91USD 270,833SEC filing ↗
2023-05-18Sankar ShyamPurchase (P)Class A Common Stock400,000USD 1.28USD 512,000SEC filing ↗
2023-05-18SLOAN HARRYPurchase (P)Class A Common Stock350,000USD 1.28USD 448,000SEC filing ↗

Form 4 evidence

43 transaction lines in the latest 365-day window; 927 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Coen Steven P.Sale (S)Class A Common Stock2,403USD 15.00USD 36,045SEC filing ↗
2026-09-15HENRY CHRISTIAN OSale (S)Class A Common Stock5,000USD 7.08USD 35,400SEC filing ↗
2026-08-24Coen Steven P.Sale (S)Class A Common Stock330USD 6.98USD 2,303SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-05Coen Steven P.Sale (S)Class A Common Stock2,403USD 15.00USD 36,045SEC filing ↗
2026-09-15HENRY CHRISTIAN OSale (S)Class A Common Stock5,000USD 7.08USD 35,400SEC filing ↗
2026-08-24Coen Steven P.Sale (S)Class A Common Stock330USD 6.98USD 2,303SEC filing ↗
2026-08-21Coen Steven P.Option exercise / conversion (M)Class A Common Stock743USD —USD —SEC filing ↗
2026-07-17Coen Steven P.Sale (S)Class A Common Stock752USD 7.90USD 5,941SEC filing ↗
2026-07-16Coen Steven P.Option exercise / conversion (M)Class A Common Stock1,486USD —USD —SEC filing ↗
2026-05-22Coen Steven P.Sale (S)Class A Common Stock307USD 8.33USD 2,557SEC filing ↗
2026-05-21Coen Steven P.Option exercise / conversion (M)Class A Common Stock743USD —USD —SEC filing ↗
2026-04-17Coen Steven P.Sale (S)Class A Common Stock324USD 7.95USD 2,576SEC filing ↗
2026-04-16Coen Steven P.Option exercise / conversion (M)Class A Common Stock743USD —USD —SEC filing ↗
2026-04-13Coen Steven P.Sale (S)Class A Common Stock33,171USD 6.41USD 212,626SEC filing ↗
2026-04-10Coen Steven P.Option exercise / conversion (M)Class A Common Stock73,921USD —USD —SEC filing ↗
2026-04-10Shetty Reshma P.Sale (S)Class A Common Stock124,727USD 6.43USD 801,995SEC filing ↗
2026-04-10Canton BarrySale (S)Class A Common Stock124,727USD 6.43USD 801,995SEC filing ↗
2026-04-09Shetty Reshma P.Option exercise / conversion (M)Class A Common Stock251,786USD —USD —SEC filing ↗
2026-04-09Canton BarryOption exercise / conversion (M)Class A Common Stock251,786USD —USD —SEC filing ↗
2026-04-09Shetty Reshma P.Sale (S)Class A Common Stock13,116USD 6.40USD 83,942SEC filing ↗
2026-04-09Kelly Jason RSale (S)Class A Common Stock109,767USD 6.40USD 702,509SEC filing ↗
2026-04-09Canton BarrySale (S)Class A Common Stock13,116USD 6.40USD 83,942SEC filing ↗
2026-04-08Shetty Reshma P.Sale (S)Class A Common Stock13,155USD 6.93USD 91,164SEC filing ↗
2026-04-08Shetty Reshma P.Option exercise / conversion (M)Class A Common Stock27,738USD —USD —SEC filing ↗
2026-04-08Kelly Jason RSale (S)Class A Common Stock97,015USD 6.93USD 672,314SEC filing ↗
2026-04-08Kelly Jason ROption exercise / conversion (M)Class A Common Stock212,949USD —USD —SEC filing ↗
2026-04-08Canton BarrySale (S)Class A Common Stock13,155USD 6.93USD 91,164SEC filing ↗
2026-04-08Canton BarryOption exercise / conversion (M)Class A Common Stock27,738USD —USD —SEC filing ↗
2026-04-07Shetty Reshma P.Option exercise / conversion (M)Class A Common Stock27,738USD —USD —SEC filing ↗
2026-04-07Kelly Jason ROption exercise / conversion (M)Class A Common Stock212,949USD —USD —SEC filing ↗
2026-04-07Canton BarryOption exercise / conversion (M)Class A Common Stock27,738USD —USD —SEC filing ↗
2026-03-16Coen Steven P.Sale (S)Class A Common Stock708USD 6.74USD 4,772SEC filing ↗
2026-03-13Coen Steven P.Option exercise / conversion (M)Class A Common Stock1,486USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerDNA
CIK0001830214
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNYSE

Data coverage

Local Form 4 history927 transaction lines from 2021-09-16 to 2026-10-05
4 P purchase lines · 686 S sale lines · 237 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.